Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DNA/RNA Synthesis
    (4)
  • Apoptosis
    (1)
  • Endogenous Metabolite
    (1)
  • HIF/HIF Prolyl-Hydroxylase
    (1)
  • NF-κB
    (1)
  • ROS
    (1)
  • Reactive Oxygen Species
    (1)
  • VEGFR
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
  • Nervous System
    (2)
  • Cardiovascular System
    (1)
  • Digestive System
    (1)
Filter
Search Result
Results for "

ape1(ref-1)

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Oligonucleotides
    1
    TargetMol | All_Pathways
  • S-Adenosyl-L-methionine disulfate tosylate
    Ademetionine disulfate tosylate
    T675297540-22-2
    S-Adenosyl-L-methionine disulfate tosylate is a methyl donor with oral activity. S-Adenosyl-L-methionine disulfate tosylate is a dietary supplement with effective antidepressant and pain-relieving effects. S-Adenosyl-L-methionine disulfate tosylate also has anti-proliferative, pro-apoptotic and anti-metastatic effects in cancer. S-Adenosyl-L-methionine can be used in the research of liver diseases and osteoarthritis.
    • $32
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • E3330
    T6823136164-66-4
    E3330 is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
    • $42
    In Stock
    Size
    QTY
  • Ape1/Ref-1 redox-IN-1
    T2147491136839-60-5
    Ape1/Ref-1 redox-IN-1 (Compound 52) is an inhibitor of the Ape1/Ref-1 redox process. It is applicable for cancer research.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • APX2009
    APX 2009
    T707331415030-15-7
    APX2009 is a second-generation redox-specific inhibitor of apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1). APX2009 significantly reduces NFκB transcriptional activity, survivin mRNA expression, and survivin protein levels. APX2009 also decreases prostate cancer cell proliferation and induces cell-cycle arrest. These findings support the application of APX2009 in studies of redox signaling, transcriptional regulation, cancer cell biology, and APE1/Ref-1-mediated molecular pathways.
    • $41
    In Stock
    Size
    QTY